10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we will discuss the 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Therapeuticsmd Inc. (TXMD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 1,192,191 | $2,634,742 | 0.02% | |
| 2. | Clearline Capital Marc Majzner | 635,222 | $1,403,841 | 0.08% | |
| 3. | ADAR1 Capital Management Daniel Schneeberger | 342,447 | $756,808 | +64% | 0.03% |
| 4. | Renaissance Technologies Jim Simons | 146,599 | $323,984 | +1% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 86,095 | $190,270 | +27% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.67 | 8,400 | $14,030.52 | 23,179 | 2025-12-23 | Filing | |
| $1.00 | 325 | $325.59 | 14,779 | 2025-04-14 | Filing | |
| $1.00 | 490 | $489.27 | 73,639 | 2025-04-14 | Filing | |
| $0.86 | 1,167 | $1,000.35 | 73,149 | 2025-04-10 | Filing | |
| $0.87 | 1,136 | $993.66 | 71,982 | 2025-04-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.24 | 4,550 | $10,187.45 | 62,565 | 2023-12-07 | Filing | |
| $2.31 | 14,500 | $33,496.45 | 67,115 | 2023-12-06 | Filing | |
| $3.64 | 692 | $2,517.57 | 11,615 | 2023-04-26 | Filing | |
| $3.65 | 1,170 | $4,275.53 | 12,307 | 2023-04-12 | Filing | |
| $5.09 | 49 | $249.41 | 11,853 | 2023-01-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 353,697 | $781,670 | 0% | |
| 2. | 344,482 | $761,305 | 0.31% | |
| 3. | 129,217 | $285,569 | 0% | |
| 4. | 115,145 | $254,470 | 0% | |
| 5. | 105,849 | $233,989 | 0% |
News See All
Is TherapeuticsMD (TXMD) Stock a Buy For 2021?
Baron Discovery Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Did Hedge Funds Drop The Ball On TherapeuticsMD Inc (TXMD) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is TherapeuticsMD Inc (TXMD) A Good Stock To Buy?
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses ...
Hedge Fund Resource Center